November 01, 2025
The osteoarthritis therapeutics market size is expected to see growth from USD 11.92 billion in 2026 to USD 24...
Read MoreNovember 13, 2025
The hospital services market is predicted to grow from USD 13.19 trillion in 2026 to USD 28.99 trillion by 203...
Read MoreDecember 29, 2025
The cardiometabolic diseases market size is anticipated to grow from USD 292.04 billion in 2026 to USD 1987.69...
Read MoreJanuary 19, 2026
The simulators market size is forecast to increase from USD 14.71 billion in 2026 to USD 27.59 billion by 2035...
Read MoreFebruary 03, 2026
The evolving usage of plasmids and vectors in various applications is driving the market’s growth. Based on market forecasts, the global viral vector and plasmid DNA manufacturing market, projected at USD 8.77 billion in 2025, is expected to reach USD 57.55 billion by 2035, growing at a CAGR of 20.7% over the forecast period....
February 03, 2026
According to market projections, the biologics sector is expected to grow from USD 485.19 billion in 2025 to USD 1009.33 billion by 2035, reflecting a CAGR of 7.6%. Biologics are advanced medicines made from living cells or organisms. They include vaccines, gene therapies, and monoclonal antibodies used to treat diseases like cancer, autoimmune dis...
February 03, 2026
The AI in genomics industry is projected to rise from USD 1.67 billion in 2025 to USD 13.88 billion by 2035, reflecting a CAGR of 23.6% over the next decade. AI in genomics helps analyze vast genetic data to uncover patterns, predict diseases, and personalize treatments. It speeds up research, enhances diagnostics, and supports drug discovery. By i...
February 03, 2026
Projections indicate that, biosimilars industry is projected to rise from USD 40.87 billion in 2025 to USD 206.75 billion by 2035, reflecting a CAGR of 17.6% over the next decade. In 2024, key advancements in biosimilars were made: CuraTeQ Biologics' Hyderabad facility earned EMA GMP certification, ensuring global-quality production. Biocon Biologi...
February 02, 2026
According to our projections, the DNA damage response (DDR) market was valued at USD 210 million in 2025 and is projected to reach USD 270.38 million in 2026, expanding rapidly to approximately USD 2,628.4 million by 2035 at a CAGR of 28.75% from 2026 to 2035....
January 30, 2026
Projections indicate that, the global synthetic tissue engineering market will increase from USD 1.72 billion in 2025 to USD 6.47 billion by 2035, experiencing a CAGR of 14.14% over the next 10 years.The synthetic tissue engineering market is growing due to its promising novel class of biomaterials, which holds momentous potential for representin...
January 29, 2026
Based on our research, the separation systems for commercial biotechnology market was valued at USD 29.57 billion in 2025 and reached USD 31.27 billion in 2026, and it is projected to expand to USD 56.72 billion by 2035, registering a CAGR of 6.84% from 2026 to 2035....
January 29, 2026
Market insights predict, the humanized mouse and rat model industry is expected to grow from USD 278.16 million in 2025 to USD 608.92 million by 2035, driven by a CAGR of 8.15%. The humanized mouse and rat model market is increasing due to growing demand for precision medicines. North America led the market due to the presence of established m...
January 29, 2026
According to forecasts, the global nanoparticle synthesis system market will grow from USD 0.78 billion in 2025 to USD 2.28 billion by 2035, with an expected CAGR of 11.34%. The nanoparticle synthesis system market is growing because nanoparticle synthesis systems have numerous major applications in healthcare, including drug delivery, tissue engin...
January 28, 2026
According to market projections, the pharmaceutical filtration sector is expected to grow from USD 14.95 billion in 2025 to USD 32.51 billion by 2035, reflecting a CAGR of 8.08%. Globally, there is a growing need for generic medications due to the significant increase in the frequency of chronic illnesses and strict drug quality control standards....
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com